Codes / ICD10CM / H02.88A

H02.88A Meibomian gland dysfunction right eye, upper and lower eyelids

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Meibomian Gland Dysfunction Right Eye, Upper and Lower Eyelids

Summary

Meibomian gland dysfunction (MGD) is a condition affecting the meibomian glands in the eyelids, which produce the oily layer of the tear film. When this dysfunction occurs in the right eye, involving both the upper and lower eyelids, it can lead to dry, irritated eyes due to inadequate lubrication of the ocular surface.

Causes

MGD is primarily caused by blockages or structural changes in the meibomian glands. These changes may result from aging, hormonal imbalances, chronic inflammation, or underlying skin conditions like rosacea. Abnormal secretion or thickening of glandular secretions can also contribute to the condition.

Risk Factors

  • Aging, as gland function tends to decline with time.
  • Hormonal fluctuations, particularly in post-menopausal individuals.
  • History of inflammatory skin conditions, such as rosacea or seborrheic dermatitis.
  • Use of contact lenses or certain medications that affect tear production.
  • Prolonged screen time, which reduces blink rate and may exacerbate symptoms.

Symptoms

  • Dryness, irritation, or a gritty sensation in the eyes.
  • Blurred vision or sensitivity to light.
  • Redness, swelling, or inflammation of the eyelids.
  • Excessive tearing or crusting along the eyelid margins.
  • Discomfort or burning sensation, especially upon waking.

Diagnosis

Diagnosis is typically based on a comprehensive eye examination, including evaluation of the eyelid margins and meibomian gland expressibility. Clinical assessment may involve slit-lamp biomicroscopy, meibography, or tear film analysis to confirm dysfunction and rule out other ocular conditions.

Treatment Options

Treatment focuses on relieving symptoms and improving gland function. Options may include warm compresses, eyelid hygiene, artificial tears, or prescription medications like topical antibiotics or anti-inflammatory agents. In severe cases, procedures such as meibomian gland expression or intense pulsed light therapy may be considered.

Prognosis and Follow-Up

Prognosis varies depending on the severity and underlying causes. With consistent management, symptoms often improve, but chronic cases may require ongoing treatment. Regular follow-up with an eye care professional is recommended to monitor progress and adjust therapy as needed.

Complications

Untreated MGD can lead to chronic dry eye, corneal irritation, or increased risk of eye infections. Severe cases may result in eyelid inflammation or damage to the ocular surface.

Lifestyle & Prevention

  • Practice good eyelid hygiene, including regular cleaning and warm compresses.
  • Avoid prolonged screen time and take breaks to reduce eye strain.
  • Use humidifiers to maintain moisture in indoor environments.
  • Avoid rubbing the eyes, which can worsen irritation.

When to Seek Professional Help

Seek care if symptoms persist despite home care, worsen over time, or are accompanied by vision changes, severe pain, or signs of infection (e.g., discharge, redness).

Tips for Medical Coders

Document the specific location (right eye, upper and lower eyelids) and any contributing factors (e.g., chronic inflammation, rosacea) to support accurate coding. Ensure clinical notes align with the diagnosis and specify the affected eyelids to justify the code selection.

Book a walkthrough

H02.88A policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.